564 related articles for article (PubMed ID: 16911288)
1. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
3. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy.
Gambichler T; Kreuter A; Tomi NS; Othlinghaus N; Altmeyer P; Skrygan M
Br J Dermatol; 2008 May; 158(5):1117-20. PubMed ID: 18363757
[TBL] [Abstract][Full Text] [Related]
5. Expression of human beta-defensins in patients with mycosis fungoides.
Gambichler T; Skrygan M; Appelhans C; Tomi NS; Reinacher-Schick A; Altmeyer P; Kreuter A
Arch Dermatol Res; 2007 Jul; 299(4):221-4. PubMed ID: 17415576
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
7. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation.
Gambichler T; Skrygan M; Tomi NS; Breuksch S; Altmeyer P; Kreuter A
Br J Dermatol; 2007 May; 156(5):951-6. PubMed ID: 17381457
[TBL] [Abstract][Full Text] [Related]
8. Pattern of mRNA expression of beta-defensins in basal cell carcinoma.
Gambichler T; Skrygan M; Huyn J; Bechara FG; Sand M; Altmeyer P; Kreuter A
BMC Cancer; 2006 Jun; 6():163. PubMed ID: 16796735
[TBL] [Abstract][Full Text] [Related]
9. Oesophageal defensin expression during Candida infection and reflux disease.
Kiehne K; Brunke G; Meyer D; Harder J; Herzig KH
Scand J Gastroenterol; 2005 May; 40(5):501-7. PubMed ID: 16036501
[TBL] [Abstract][Full Text] [Related]
10. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
[TBL] [Abstract][Full Text] [Related]
11. Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study.
El-Mofty M; Mostafa W; Esmat S; Youssef R; Bousseila M; Nagi N; Shaker O; Abouzeid A
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):93-100. PubMed ID: 15030594
[TBL] [Abstract][Full Text] [Related]
12. Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31.
Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A
Int J Dermatol; 2016 Jul; 55(7):e380-5. PubMed ID: 26748443
[TBL] [Abstract][Full Text] [Related]
13. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.
Gambichler T; Skrygan M; Tomi NS; Othlinghaus N; Brockmeyer NH; Altmeyer P; Kreuter A
Int Arch Allergy Immunol; 2008; 147(1):17-24. PubMed ID: 18446049
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
[TBL] [Abstract][Full Text] [Related]
15. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-defensins in gingival health and in periodontal disease.
Bissell J; Joly S; Johnson GK; Organ CC; Dawson D; McCray PB; Guthmiller JM
J Oral Pathol Med; 2004 May; 33(5):278-85. PubMed ID: 15078488
[TBL] [Abstract][Full Text] [Related]
18. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy.
Schnopp C; Rad R; Weidinger A; Weidinger S; Ring J; Eberlein B; Ollert M; Mempel M
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):81-5. PubMed ID: 17523929
[TBL] [Abstract][Full Text] [Related]
19. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of human beta-defensin-2 in osteoarthritic cartilage.
Varoga D; Paulsen FP; Kohrs S; Grohmann S; Lippross S; Mentlein R; Tillmann BN; Goldring MB; Besch L; Pufe T
J Pathol; 2006 Jun; 209(2):166-73. PubMed ID: 16622898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
